We have merged with Bristol Myers Squibb creating a leading biopharma company, ideally positioned to discover, develop and deliver innovative medicines for patients fighting serious diseases. Visit www.bms.com to learn more about our work to produce the next generation of medicines to treat cancer and other serious diseases. For more information on the acquisition, see our press release at: http://bit.ly/3UbQcnl
View Top Employees from Juno Therapeutics, Inc.| Website | http://www.bms.com |
| Ticker | NASDAQ:JUNO |
| Revenue | $111 million |
| Funding | $1.5 billion |
| Employees | 223 (223 on RocketReach) |
| Founded | 2013 |
| Address | 400 Dexter Ave N., Seattle, Washington 98109, US |
| Phone | (206) 582-1600 |
| Technologies |
JavaScript,
HTML,
Twitter
+88 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Science and Engineering, Immunotherapy, Healthcare, Health Care, Drug Manufacturing & Research, Therapeutics, Wellness |
| Web Rank | 2 Million |
| Keywords | Targeted Cancer Therapies, Innovative Cancer Treatments |
| Competitors | Adaptimmune, CureVac, Dendreon, Kite Pharma, Sage Therapeutics |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Juno Therapeutics, Inc. employee's phone or email?
Juno Therapeutics, Inc. Questions
The Juno Therapeutics, Inc. annual revenue was $111 million in 2024.
Hyam Levitsky is the Executive Vice President Research, Chief Scientific Officer of Juno Therapeutics, Inc..
223 people are employed at Juno Therapeutics, Inc..
Juno Therapeutics, Inc. is based in Seattle, Washington.
The NAICS codes for Juno Therapeutics, Inc. are [541, 3254, 32541, 54, 5417, 32, 325].
The SIC codes for Juno Therapeutics, Inc. are [28, 283].
Top Juno Therapeutics, Inc. Employees
-
ViewHyam Levitsky
Executive Vice President Research, Chief Scientific Officer at Juno Therapeutics, Inc.
Seattle, Washington, United States25 -
ViewHyam Levitsky
Executive Vice President Research, Chief Scientific Officer at Juno Therapeutics, Inc.
Seattle, Washington, United States13 -
12
-
View
Lauren Ross
Associate Director, Strategic Sourcing and External Manufacturing, Cell Therapy at Juno Therapeutics, Inc.
California, United States34
Related Companies
